⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20234345 | 1.00 | — | — | |
| SCHEMBL4419586 | 1.00 | — | — | |
| SCHEMBL12816981 | 1.00 | — | — | |
| SCHEMBL26220759 | 1.00 | — | — | |
| SCHEMBL2614515 | 1.00 | — | — | |
| SCHEMBL2622546 | 1.00 | — | — | |
| SCHEMBL3717111 | 1.00 | — | — | |
| SCHEMBL17028487 | 1.00 | — | — | |
| Water SCHEMBL28199872 | 0.96 | FUCA1 (0.35) | — | |
| Hydrogen Sulfide SCHEMBL27937063 | 0.96 | FUCA1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3442354-B1 | FORMULATION AND PRODUCTION OF SPINACH EXTRACT WITH BETA ECDYSON | DR GOETZ GMBH (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-3713933-B1 | CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE | H LUNDBECK AS (DK) | 2026-03-25 | — | — | EP | claimed |
| EP-4601703-B1 | CONJUGATES COMPRISING CLEAVABLE LINKERS | ASTRAZENECA AB (SE) | 2026-03-25 | — | — | EP | claimed |
| CN-119143735-A | Novel compounds | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-113795487-B | Novel compounds | 葛兰素史密斯克莱知识产权发展有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118742576-A | Novel hyaluronic acid derivatives as innovative fillers | 维库有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-111840271-B | Novel application of glycoside derivative | 北京盈科瑞创新药物研究有限公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2024068511-A1 | DITERPENOID DERIVATIVES AS INHIBITORS OF SGLT2 | Société des Produits Nestlé S.A. (CH) | 2024-04-04 | — | — | WO | claimed |
| CN-114716425-B | Synthesis method of aromatic heterocyclic substituted methylene compound | 沧州那瑞化学科技有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-114540819-B | Corrosion inhibitor based on pyracantha fortuneana fruits, preparation method and application | 重庆科技学院 | 2023-08-22 | — | — | CN | claimed |
| CN-111471031-B | Glycoside derivative and preparation method and application thereof | 北京盈科瑞创新药物研究有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115518058-A | Application of N-cycloalkyl substituted aromatic methylamine compound in preparation of antiviral drug, structure and preparation method | 河北医科大学 | 2022-12-27 | — | — | CN | claimed |
| CN-115427049-A | Inhibitors of malaria and plasmodium falciparum hexose transporters and uses thereof | 清华大学 | 2022-12-02 | — | — | CN | claimed |
| EP-3704114-B1 | SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2022-11-23 | — | — | EP | claimed |
| CN-114716425-A | Synthetic method of aromatic heterocyclic substituted methylene compound | 沧州那瑞化学科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-RE49080-E1 | Glycoside derivatives and uses thereof | NOVARTIS AG (CH) | 2022-05-24 | — | — | US | claimed |
| EP-3966210-A1 | NOVEL COMPOUNDS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2022-03-16 | — | — | EP | claimed |
| CN-108883122-A | C-glycoside compounds useful for the treatment of diseases | 菲姆布里昂医疗公司 | 2018-11-23 | — | — | CN | claimed |
| WO-2017030684-A1 | DEHYDRATIVE CYCLIZATION OF PENTITOLS USING WATER-TOLERANT LEWIS ACID CATALYSTS UNDER MILD CONDITIONS AND DERIVATIVES | ARCHER DANIELS MIDLAND COMPANY (US) | 2017-02-23 | — | — | WO | claimed |
| WO-2010128152-A1 | FUSED HETEROCYCLIC C-GLYCOSIDES FOR THE TREATMENT OF DIABETES | NOVARTIS AG (CH) | 2010-11-11 | — | — | WO | claimed |